Doxil®--the first FDA-approved nano-drug: lessons learned.
Explore this paper's citation graph
Summary
This review summarizes historical and scientific perspectives of Doxil development and lessons learned from its development and 20 years of its use and demonstrates the obligatory need for applying an understanding of the cross talk between physicochemical, nano-technological, and biological principles.
- Type
- review
- Published
- 2012-06-10
- Cited by
- 4,286
- References
- 134
- OpenAlex
- https://openalex.org/W1989230986
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20734524
Keywords
Liposome, Drug, Pharmacology, Medicine, Doxorubicin
References
- Sterically stabilized liposomes.
- Preparation and Characterization of Doxorubicin-Loaded Sterically Stabilized Immunoliposomes
- Hydration of polyethylene glycol-grafted liposomes.
- Changes of vascular pattern of tumors and surrounding tissue during different phases of metastatic growth.
- A New Look at Lipid-Membrane Structure in Relation to Drug Research
- Introduction and overview of peptide and protein pegylation.
- Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
- Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies.
- Transport and Diffusion Across Cell Membranes
- Liposomes: preparation, characterization, and preservation.
- Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
- Liposomal protection of adriamycin-induced cardiotoxicity in mice.
- Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice
- Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
- DRV Liposomal Bupivacaine: Preparation, Characterization, and In Vivo Evaluation in Mice
- Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
- Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and Dogs
- Reduced UV-Induced Degradation of Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes
- The anthracyclines: will we ever find a better doxorubicin?
- Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain.
Cited by
- QUANTIFICATION OF FACTORS GOVERNING DRUG RELEASE KINETICS FROM NANOPARTICLES: A COMBINED EXPERIMENTAL AND MECHANISTIC MODELING APPROACH
- Can carbon nanotube-liposome conjugates address the issues associated with carbon nanotubes in drug delivery?
- Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
- Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
- Efficient Drug Delivery of Paclitaxel Glycoside: A Novel Solubility Gradient Encapsulation into Liposomes Coupled with Immunoliposomes Preparation
- Nanomedicine-mediated cancer stem cell therapy.
- Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.
- To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes
- Liposomal Drug Product Development and Quality: Current US Experience and Perspective
- Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint.
- Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect
- Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy.
- The Critical Role of Mechanism-Based Models for Understanding and Predicting Liposomal Drug Loading, Binding and Release Kinetics
- Stabilisation, modification, delivery and treatment of phospholipid based vesicles for applications in advanced wound management
- Design, synthesis, and functionalization of nanomaterials for therapeutic drug delivery.
- POLYMER MICELLES FOR TUNABLE DRUG RELEASE AND ENHANCED ANTITUMOR EFFICACY
- Glutamate-Leucine Block Copolypeptides for Drug Delivery
- Anti-GD2 Etoposide-Loaded Immunoliposomes for the Treatment of GD2 Positive Tumors
- A nanoliposome-based drug delivery system for cancer
- Enhancing Cisplatin Delivery and Anti-tumor Efficacy Using Hyperthermia
Related papers
- Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
- An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
- Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
- Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin.
- A Liposomal Formulation of Simvastatin and Doxorubicin for Improved Cardioprotective and Anti-Cancer Effect.
- Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
- Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
- Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
- Preclinical and Clinical Experience with a Doxorubicin-Liposome Preparation